Bayer AG (FRA:BAYN) received a €103.00 ($114.44) price objective from equities research analysts at Bankhaus Lampe in a note issued to investors on Wednesday. The firm currently has a a “buy” rating on the stock.

Several other research analysts also recently commented on BAYN. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Bayer AG in a report on Wednesday. Commerzbank AG set a €110.00 ($122.22) target price on shares of Bayer AG and gave the stock a “buy” rating in a report on Wednesday. Warburg Research set a €118.00 ($131.11) target price on shares of Bayer AG and gave the stock a “buy” rating in a report on Wednesday. Goldman Sachs Group Inc. set a €129.00 ($143.33) target price on shares of Bayer AG and gave the stock a “buy” rating in a report on Wednesday. Finally, BNP Paribas set a €105.00 ($116.67) target price on shares of Bayer AG and gave the stock a “neutral” rating in a report on Friday, July 15th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of €112.17 ($124.63).

Bayer AG (FRA:BAYN) opened at 92.385 on Wednesday. Bayer AG has a one year low of €83.87 and a one year high of €127.21. The company has a market cap of €76.40 billion and a PE ratio of 16.967. The firm has a 50-day moving average of €95.47 and a 200-day moving average of €95.90.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/bayer-ag-bayn-given-a-103-00-price-target-by-bankhaus-lampe-analysts-3.html

About Bayer AG

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.